ArticleFrontiers in cardiovascular medicine2026
Traumatic brain injury in patients with mechanical heart valves on lifelong anticoagulation: incidence, management, and outcomes of intracranial hemorrhage.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Patients with mechanical heart valves require lifelong anticoagulation, exposing them to a substantially elevated risk of hemorrhagic complications following traumatic injury. Traumatic brain injury (TBI) in this population represents a particularly challenging clinical dilemma, as the coexistence of intracranial hemorrhage and the obligatory need for anticoagulation places competing physiologic imperatives in direct conflict. Despite the clinical relevance of this scenario, data on the incidence, management, and outcomes of TBI in anticoagulated mechanical valve patients remain scarce. This study aimed to characterize the incidence and severity of TBI and intracranial hemorrhage in this population, to evaluate the impact of hemorrhage on composite good outcome, and to compare outcomes between surgical and conservative management strategies. Methods: We conducted a retrospective observational cohort study of patients with mechanical heart valves who sustained at least one traumatic event at the University Hospital Zurich during 2012 and 2023. The primary outcome was a composite good outcome at one month, defined as absence of neurological sequelae, no new bleeding, and no progression of intracranial hemorrhage. Anticoagulation reversal strategies were recorded for all patients. Admission INR values were extracted from emergency laboratory records where available. Results: Among 60 patients with mechanical heart valves, 43 (71.7%) sustained at least one TBI, yielding 50 TBI events over the study period. The majority of TBIs were mild (90%), with a median patient age at first TBI of 73 years (interquartile range 56.5-79.8). Intracranial hemorrhage was present in 30 of 50 TBIs (60%). A composite good outcome was achieved in 18 of 20 TBIs (90%) without intracranial hemorrhage, compared with 20 of 30 TBIs (66.7%) with intracranial hemorrhage. Among hemorrhagic TBIs, good outcome was observed in 5 of 9 surgically managed cases (55.6%) and 15 of 21 conservatively managed cases (71.4%). Conclusions: Intracranial hemorrhage following TBI is common in anticoagulated mechanical valve patients and is associated with a lower rate of composite good outcome compared to TBI without hemorrhage (66.7% vs. 90.0%). Among haemorrhagic TBI events, composite good outcomes were numerically more frequent with conservative than with surgical management (71.4% vs. 55.6%); however, given the small number of surgical cases (
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.